1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	World	_	_	NNP	_	_	_	_	_
3	Health	_	_	NNP	_	_	_	_	_
4	Organisation	_	_	NNP	_	_	_	_	_
5	recommends	_	_	VBZ	_	_	_	_	_
6	exclusive	_	_	JJ	_	_	_	_	_
7	breastfeeding	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	infants	_	_	NNS	_	_	_	_	_
10	up	_	_	IN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	six	_	_	CD	_	_	_	_	_
13	months	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	age	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	based	_	_	VBN	_	_	_	_	_
18	on	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	clear	_	_	JJ	_	_	_	_	_
21	health	_	_	NN	_	_	_	_	_
22	benefits	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	breastfeeding	_	_	VBG	_	_	_	_	_
25	on	_	_	IN	_	_	_	_	_
26	mother-infant	_	_	NN	_	_	_	_	_
27	dyad	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	consensus	_	_	NN	_	_	_	_	_
7	regarding	_	_	VBG	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	association	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	breastfeeding	_	_	VBG	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	reduced	_	_	VBN	_	_	_	_	_
15	risk	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	respiratory	_	_	JJ	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	gastro-intestinal	_	_	JJ	_	_	_	_	_
20	infections	_	_	NNS	_	_	_	_	_
21	during	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	first	_	_	JJ	_	_	_	_	_
24	year	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	life	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Infants	_	_	NNS	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	who	_	_	WP	_	_	_	_	_
4	were	_	_	VBD	_	_	_	_	_
5	breastfed	_	_	VBN	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	longer	_	_	JJR	_	_	_	_	_
8	periods	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	may	_	_	MD	_	_	_	_	_
11	also	_	_	RB	_	_	_	_	_
12	have	_	_	VB	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	lower	_	_	JJR	_	_	_	_	_
15	risk	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	developing	_	_	VBG	_	_	_	_	_
18	obesity	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	type	_	_	NN	_	_	_	_	_
21	II	_	_	CD	_	_	_	_	_
22	diabetes	_	_	NNS	_	_	_	_	_
23	at	_	_	IN	_	_	_	_	_
24	adulthood	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	mothers	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	breastfeeding	_	_	NN	_	_	_	_	_
5	could	_	_	MD	_	_	_	_	_
6	limit	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	risk	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	developing	_	_	VBG	_	_	_	_	_
11	ovarian	_	_	JJ	_	_	_	_	_
12	cancer	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	type	_	_	NN	_	_	_	_	_
15	II	_	_	CD	_	_	_	_	_
16	diabetes	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Despite	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	benefits	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	breastfeeding	_	_	NN	_	_	_	_	_
6	prevalence	_	_	NN	_	_	_	_	_
7	remains	_	_	VBZ	_	_	_	_	_
8	relatively	_	_	RB	_	_	_	_	_
9	low	_	_	JJ	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	particularly	_	_	RB	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	several	_	_	JJ	_	_	_	_	_
14	high-income	_	_	JJ	_	_	_	_	_
15	countries	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	North	_	_	NNP	_	_	_	_	_
18	America	_	_	NNP	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	Europe	_	_	NNP	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	where	_	_	WRB	_	_	_	_	_
23	only	_	_	RB	_	_	_	_	_
24	40	_	_	CD	_	_	_	_	_
25	%	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	mothers	_	_	NNS	_	_	_	_	_
28	breastfeed	_	_	VBP	_	_	_	_	_
29	six	_	_	CD	_	_	_	_	_
30	months	_	_	NNS	_	_	_	_	_
31	after	_	_	IN	_	_	_	_	_
32	delivery	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Exclusive	_	_	JJ	_	_	_	_	_
2	breastfeeding	_	_	NN	_	_	_	_	_
3	rate	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	about	_	_	RB	_	_	_	_	_
6	60	_	_	CD	_	_	_	_	_
7	%	_	_	NN	_	_	_	_	_
8	at	_	_	IN	_	_	_	_	_
9	four	_	_	CD	_	_	_	_	_
10	months	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	Scandinavian	_	_	JJ	_	_	_	_	_
13	countries	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	35	_	_	CD	_	_	_	_	_
16	%	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	Netherlands	_	_	NNP	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	16	_	_	CD	_	_	_	_	_
22	%	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	UK	_	_	NNP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	10	_	_	CD	_	_	_	_	_
29	%	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	France	_	_	NNP	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Early	_	_	JJ	_	_	_	_	_
2	cessation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	breastfeeding	_	_	NN	_	_	_	_	_
5	clearly	_	_	RB	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	multifactorial	_	_	JJ	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	main	_	_	JJ	_	_	_	_	_
5	factors	_	_	NNS	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	maternal	_	_	JJ	_	_	_	_	_
9	perception	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	insufficient	_	_	JJ	_	_	_	_	_
12	milk	_	_	NN	_	_	_	_	_
13	secretion	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	quell	_	_	VB	_	_	_	_	_
16	infant	_	_	NN	_	_	_	_	_
17	’s	_	_	POS	_	_	_	_	_
18	hunger	_	_	NN	_	_	_	_	_
19	or	_	_	CC	_	_	_	_	_
20	support	_	_	VB	_	_	_	_	_
21	infant	_	_	NN	_	_	_	_	_
22	growth	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	leads	_	_	VBZ	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	early	_	_	JJ	_	_	_	_	_
27	cessation	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	breastfeeding	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	35	_	_	CD	_	_	_	_	_
32	%	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	cases	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Perception	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	insufficient	_	_	JJ	_	_	_	_	_
4	milk	_	_	NN	_	_	_	_	_
5	production	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	complex	_	_	JJ	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	multifactorial	_	_	JJ	_	_	_	_	_
11	issue	_	_	NN	_	_	_	_	_
12	that	_	_	WDT	_	_	_	_	_
13	can	_	_	MD	_	_	_	_	_
14	have	_	_	VB	_	_	_	_	_
15	biological	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	social	_	_	JJ	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	or	_	_	CC	_	_	_	_	_
20	psychological	_	_	JJ	_	_	_	_	_
21	determinants	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	it	_	_	PRP	_	_	_	_	_
25	often	_	_	RB	_	_	_	_	_
26	remains	_	_	VBZ	_	_	_	_	_
27	unclear	_	_	JJ	_	_	_	_	_
28	whether	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	low	_	_	JJ	_	_	_	_	_
31	milk	_	_	NN	_	_	_	_	_
32	secretion	_	_	NN	_	_	_	_	_
33	is	_	_	VBZ	_	_	_	_	_
34	real	_	_	JJ	_	_	_	_	_
35	or	_	_	CC	_	_	_	_	_
36	only	_	_	RB	_	_	_	_	_
37	perceived	_	_	VBN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	as	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	result	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	lack	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	objective	_	_	JJ	_	_	_	_	_
12	marker	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	insufficient	_	_	JJ	_	_	_	_	_
15	milk	_	_	NN	_	_	_	_	_
16	production	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	importance	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	maternal	_	_	JJ	_	_	_	_	_
22	psychology	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	breastfeeding	_	_	NN	_	_	_	_	_
25	duration	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	perceived	_	_	VBN	_	_	_	_	_
28	milk	_	_	NN	_	_	_	_	_
29	insufficiency	_	_	NN	_	_	_	_	_
30	is	_	_	VBZ	_	_	_	_	_
31	probably	_	_	RB	_	_	_	_	_
32	much	_	_	RB	_	_	_	_	_
33	more	_	_	RBR	_	_	_	_	_
34	common	_	_	JJ	_	_	_	_	_
35	than	_	_	IN	_	_	_	_	_
36	true	_	_	JJ	_	_	_	_	_
37	insufficient	_	_	JJ	_	_	_	_	_
38	production	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	True	_	_	JJ	_	_	_	_	_
2	insufficient	_	_	JJ	_	_	_	_	_
3	milk	_	_	NN	_	_	_	_	_
4	secretion	_	_	NN	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	result	_	_	VB	_	_	_	_	_
7	from	_	_	IN	_	_	_	_	_
8	many	_	_	JJ	_	_	_	_	_
9	causes	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	ranging	_	_	VBG	_	_	_	_	_
12	from	_	_	IN	_	_	_	_	_
13	inability	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	lactate	_	_	VB	_	_	_	_	_
16	due	_	_	JJ	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	breast	_	_	NN	_	_	_	_	_
19	abnormalities	_	_	NNS	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	endocrine	_	_	JJ	_	_	_	_	_
22	disorder	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	5	_	_	CD	_	_	_	_	_
25	%	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	women	_	_	NNS	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	difficulties	_	_	NNS	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	breastfeeding	_	_	VBG	_	_	_	_	_
33	management	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	maternal	_	_	JJ	_	_	_	_	_
36	stress	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	anxiety	_	_	NN	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	or	_	_	CC	_	_	_	_	_
41	early	_	_	JJ	_	_	_	_	_
42	food	_	_	NN	_	_	_	_	_
43	diversification	_	_	NN	_	_	_	_	_
44	in	_	_	IN	_	_	_	_	_
45	the	_	_	DT	_	_	_	_	_
46	infant	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	maternal	_	_	JJ	_	_	_	_	_
3	milk	_	_	NN	_	_	_	_	_
4	production	_	_	NN	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	often	_	_	RB	_	_	_	_	_
8	increased	_	_	VBN	_	_	_	_	_
9	through	_	_	IN	_	_	_	_	_
10	psychological	_	_	JJ	_	_	_	_	_
11	support	_	_	NN	_	_	_	_	_
12	or	_	_	CC	_	_	_	_	_
13	maternal	_	_	JJ	_	_	_	_	_
14	breastfeeding	_	_	NN	_	_	_	_	_
15	education	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	many	_	_	JJ	_	_	_	_	_
18	healthy	_	_	JJ	_	_	_	_	_
19	mothers	_	_	NNS	_	_	_	_	_
20	are	_	_	VBP	_	_	_	_	_
21	eager	_	_	JJ	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	enhance	_	_	VB	_	_	_	_	_
24	their	_	_	PRP$	_	_	_	_	_
25	milk	_	_	NN	_	_	_	_	_
26	production	_	_	NN	_	_	_	_	_
27	through	_	_	IN	_	_	_	_	_
28	various	_	_	JJ	_	_	_	_	_
29	nutritional	_	_	JJ	_	_	_	_	_
30	supplements	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	drugs	_	_	NNS	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	herbal	_	_	JJ	_	_	_	_	_
5	preparations	_	_	NNS	_	_	_	_	_
6	have	_	_	VBP	_	_	_	_	_
7	traditionally	_	_	RB	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	prescribed	_	_	VBN	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	galactologues	_	_	NNS	_	_	_	_	_
12	:	_	_	:	_	_	_	_	_
13	i.	_	_	FW	_	_	_	_	_
14	e.	_	_	FW	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	substances	_	_	NNS	_	_	_	_	_
17	that	_	_	WDT	_	_	_	_	_
18	promote	_	_	VBP	_	_	_	_	_
19	initiation	_	_	NN	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	increase	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	lactation	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Drugs	_	_	NNS	_	_	_	_	_
2	like	_	_	IN	_	_	_	_	_
3	domperidone®	_	_	NN	_	_	_	_	_
4	or	_	_	CC	_	_	_	_	_
5	metoclopramide®	_	_	NN	_	_	_	_	_
6	carry	_	_	VBP	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	risk	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	adverse	_	_	JJ	_	_	_	_	_
11	side	_	_	NN	_	_	_	_	_
12	effects	_	_	NNS	_	_	_	_	_
13	such	_	_	JJ	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	arrhythmia	_	_	NN	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	hypothyroidism	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	mother-children	_	_	JJ	_	_	_	_	_
20	dyad	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	That	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	why	_	_	WRB	_	_	_	_	_
4	herbal	_	_	JJ	_	_	_	_	_
5	galactologues	_	_	NNS	_	_	_	_	_
6	like	_	_	IN	_	_	_	_	_
7	fennel	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	anise	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	barley	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	milk	_	_	NN	_	_	_	_	_
14	thistle	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	garlic	_	_	NN	_	_	_	_	_
18	are	_	_	VBP	_	_	_	_	_
19	becoming	_	_	VBG	_	_	_	_	_
20	more	_	_	RBR	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	more	_	_	RBR	_	_	_	_	_
23	popular	_	_	JJ	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	increasing	_	_	VBG	_	_	_	_	_
26	lactation	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	herbal	_	_	JJ	_	_	_	_	_
4	compounds	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	fenugreek	_	_	NN	_	_	_	_	_
7	probably	_	_	RB	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	most	_	_	RBS	_	_	_	_	_
11	widely	_	_	RB	_	_	_	_	_
12	consumed	_	_	VBN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Fenugreek	_	_	NNP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	used	_	_	VBN	_	_	_	_	_
5	since	_	_	IN	_	_	_	_	_
6	antiquity	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	traditional	_	_	JJ	_	_	_	_	_
9	Persian	_	_	JJ	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	Chinese	_	_	JJ	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	Egyptian	_	_	JJ	_	_	_	_	_
15	medicine	_	_	NN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	its	_	_	PRP$	_	_	_	_	_
18	range	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	therapeutic	_	_	JJ	_	_	_	_	_
21	effects	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	now	_	_	RB	_	_	_	_	_
4	increasingly	_	_	RB	_	_	_	_	_
5	consumed	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	Western	_	_	JJ	_	_	_	_	_
8	countries	_	_	NNS	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	its	_	_	PRP$	_	_	_	_	_
11	presumed	_	_	VBN	_	_	_	_	_
12	protective	_	_	JJ	_	_	_	_	_
13	effects	_	_	NNS	_	_	_	_	_
14	against	_	_	IN	_	_	_	_	_
15	diabetes	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	atherosclerosis	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	inflammation	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	hypertriglyceridemia	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	as	_	_	RB	_	_	_	_	_
25	well	_	_	RB	_	_	_	_	_
26	as	_	_	IN	_	_	_	_	_
27	its	_	_	PRP$	_	_	_	_	_
28	putative	_	_	JJ	_	_	_	_	_
29	role	_	_	NN	_	_	_	_	_
30	as	_	_	IN	_	_	_	_	_
31	a	_	_	DT	_	_	_	_	_
32	galactologue	_	_	NN	_	_	_	_	_
33	due	_	_	JJ	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	part	_	_	NN	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	trigonelline	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	one	_	_	CD	_	_	_	_	_
42	of	_	_	IN	_	_	_	_	_
43	its	_	_	PRP$	_	_	_	_	_
44	main	_	_	JJ	_	_	_	_	_
45	active	_	_	JJ	_	_	_	_	_
46	ingredients	_	_	NNS	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	however	_	_	RB	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	little	_	_	JJ	_	_	_	_	_
7	evidence	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	its	_	_	PRP$	_	_	_	_	_
10	effectiveness	_	_	NN	_	_	_	_	_
11	on	_	_	IN	_	_	_	_	_
12	milk	_	_	NN	_	_	_	_	_
13	yield	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Whereas	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	positive	_	_	JJ	_	_	_	_	_
4	effect	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	fenugreek	_	_	NN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	milk	_	_	NN	_	_	_	_	_
9	production	_	_	NN	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	observed	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	various	_	_	JJ	_	_	_	_	_
14	mammals	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	such	_	_	JJ	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	rabbit	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	buffalo	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	goat	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	or	_	_	CC	_	_	_	_	_
25	ewe	_	_	NN	_	_	_	_	_
26	;	_	_	:	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	wide	_	_	JJ	_	_	_	_	_
29	range	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	doses	_	_	NNS	_	_	_	_	_
32	tested	_	_	VBN	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	from	_	_	IN	_	_	_	_	_
35	180	_	_	CD	_	_	_	_	_
36	mg	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	kg-1	_	_	NN	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_
3	d-1	_	_	CD	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	2.1	_	_	CD	_	_	_	_	_
6	g.	_	_	NN	_	_	_	_	_
7	kg-1	_	_	NN	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_
9	d-1	_	_	CD	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	led	_	_	VBD	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	large	_	_	JJ	_	_	_	_	_
14	discrepancies	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	reported	_	_	VBN	_	_	_	_	_
18	effect	_	_	NN	_	_	_	_	_
19	on	_	_	IN	_	_	_	_	_
20	milk	_	_	NN	_	_	_	_	_
21	production	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	ranging	_	_	VBG	_	_	_	_	_
24	from	_	_	IN	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	10	_	_	CD	_	_	_	_	_
27	%	_	_	NN	_	_	_	_	_
28	increase	_	_	NN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	110	_	_	CD	_	_	_	_	_
32	%	_	_	NN	_	_	_	_	_
33	increase	_	_	NN	_	_	_	_	_
34	)	_	_	-RRB-	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	which	_	_	WDT	_	_	_	_	_
37	makes	_	_	VBZ	_	_	_	_	_
38	it	_	_	PRP	_	_	_	_	_
39	difficult	_	_	JJ	_	_	_	_	_
40	to	_	_	TO	_	_	_	_	_
41	determine	_	_	VB	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	effective	_	_	JJ	_	_	_	_	_
44	dose	_	_	NN	_	_	_	_	_
45	of	_	_	IN	_	_	_	_	_
46	fenugreek	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	failed	_	_	VBD	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	demonstrate	_	_	VB	_	_	_	_	_
8	an	_	_	DT	_	_	_	_	_
9	effect	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	rabbits	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	goats	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	milk	_	_	NN	_	_	_	_	_
6	production	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	measured	_	_	VBN	_	_	_	_	_
9	either	_	_	CC	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	weight	_	_	NN	_	_	_	_	_
13	–	_	_	:	_	_	_	_	_
14	suckle	_	_	NN	_	_	_	_	_
15	–	_	_	:	_	_	_	_	_
16	weight	_	_	NN	_	_	_	_	_
17	method	_	_	NN	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	rabbit	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	or	_	_	CC	_	_	_	_	_
24	by	_	_	IN	_	_	_	_	_
25	milking	_	_	VBG	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	larger	_	_	JJR	_	_	_	_	_
29	animals	_	_	NNS	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	latter	_	_	JJ	_	_	_	_	_
3	methods	_	_	NNS	_	_	_	_	_
4	do	_	_	VBP	_	_	_	_	_
5	not	_	_	RB	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	however	_	_	RB	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	directly	_	_	RB	_	_	_	_	_
10	assess	_	_	VB	_	_	_	_	_
11	milk	_	_	NN	_	_	_	_	_
12	production	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	response	_	_	NN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	physiological	_	_	JJ	_	_	_	_	_
17	suckling	_	_	NN	_	_	_	_	_
18	by	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	pups	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	evaluated	_	_	VBD	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	effectiveness	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	fenugreek	_	_	NN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	increase	_	_	VB	_	_	_	_	_
12	milk	_	_	NN	_	_	_	_	_
13	production	_	_	NN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	aim	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	productivity	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	under	_	_	IN	_	_	_	_	_
21	otherwise	_	_	RB	_	_	_	_	_
22	optimal	_	_	JJ	_	_	_	_	_
23	conditions	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	lactation	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	opposed	_	_	VBN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	mothers	_	_	NNS	_	_	_	_	_
31	challenged	_	_	VBN	_	_	_	_	_
32	by	_	_	IN	_	_	_	_	_
33	their	_	_	PRP$	_	_	_	_	_
34	perception	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	insufficient	_	_	JJ	_	_	_	_	_
37	milk	_	_	NN	_	_	_	_	_
38	production	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	none	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	these	_	_	DT	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	evaluated	_	_	VBD	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	metabolic	_	_	JJ	_	_	_	_	_
10	status	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	mother-infant	_	_	NN	_	_	_	_	_
13	dyad	_	_	NN	_	_	_	_	_
14	following	_	_	VBG	_	_	_	_	_
15	fenugreek	_	_	NN	_	_	_	_	_
16	supplementation	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	true	_	_	JJ	_	_	_	_	_
5	efficacy	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	fenugreek	_	_	NN	_	_	_	_	_
8	on	_	_	IN	_	_	_	_	_
9	milk	_	_	NN	_	_	_	_	_
10	production	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	animal	_	_	NN	_	_	_	_	_
14	model	_	_	NN	_	_	_	_	_
15	submitted	_	_	VBN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	breastfeeding	_	_	VBG	_	_	_	_	_
19	challenge	_	_	NN	_	_	_	_	_
20	remains	_	_	VBZ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	be	_	_	VB	_	_	_	_	_
23	ascertained	_	_	VBN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_

